Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CERT | US
-0.28
-2.46%
Healthcare
Biotechnology
30/06/2024
04/10/2024
11.09
11.16
11.38
11.06
Certara Inc. together with its subsidiaries provides software products and technology-enabled services to customers for biosimulation in drug discovery preclinical and clinical research regulatory submissions and market access. It offers medicines to patients using biosimulation software technology and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation empirical biosimulation drug development and regulatory strategy clinical pharmacology model-based meta-analysis regulatory writing and medical communications regulatory operations and market access. Further company offers software comprising mechanistic biosimulation platform empirical PK/PD biosimulation platform data standardization and compliance software scientific informatics platform clinical outcomes databases for biosimulation authoring and management of regulatory submissions platform and market access communication platform. The company serves biopharmaceutical companies and academic and government institutions. It has operations in the United States Australia Canada China France Germany India Italy Japan Luxembourg the Netherlands the Philippines Poland Portugal Spain Switzerland and the United Kingdom. Certara Inc. was founded in 2008 and is headquartered in Princeton New Jersey.
View LessValue Stock (Price to Book < 3)
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
62.1%1 month
47.6%3 months
54.0%6 months
48.8%-
25.19
1.81
0.30
0.20
1.37K
5.43
-
70.72M
1.78B
1.78B
-
-9.69
-14.10
3.20
-7.35
3.16
3.58
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.63
Range1M
1.70
Range3M
6.58
Rel. volume
0.57
Price X volume
10.16M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Ligand Pharmaceuticals Incorporated | LGND | Biotechnology | 104.78 | 1.95B | 4.83% | 42.52 | 0.98% |
BEAM THERAPEUTICS INC. | BEAM | Biotechnology | 23.41 | 1.93B | -0.38% | n/a | 19.35% |
Galapagos NV | GLPG | Biotechnology | 29.19 | 1.92B | 2.89% | 55.25 | 0.00% |
Mirum Pharmaceuticals Inc | MIRM | Biotechnology | 39.26 | 1.87B | -5.37% | n/a | 138.24% |
Intellia Therapeutics Inc | NTLA | Biotechnology | 17.99 | 1.83B | -3.02% | n/a | 10.95% |
VIRIDIAN THERAPEUTICS ORS INC | VRDN | Biotechnology | 23.92 | 1.83B | -1.36% | n/a | 3.96% |
MannKind Corporation | MNKD | Biotechnology | 6.49 | 1.78B | 3.18% | 124.00 | -149.80% |
Kiniksa Pharmaceuticals Ltd | KNSA | Biotechnology | 24.48 | 1.74B | -0.20% | n/a | 2.62% |
Recursion Pharmaceuticals Inc. Class A Common Stock | RXRX | Biotechnology | 6.11 | 1.72B | 0.00% | n/a | 15.38% |
Arvinas Inc | ARVN | Biotechnology | 24.96 | 1.71B | 1.05% | n/a | 0.38% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Fox Factory Holding Corp | FOXF | Recreational Vehicles | 40.42 | 1.68B | 0.17% | 42.66 | 64.69% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 57.84 | 1.66B | 0.98% | 21.48 | 56.33% |
Steelcase Inc | SCS | Building Products & Equipment | 12.97 | 1.47B | 0.78% | 12.50 | 65.47% |
REV Group Inc | REVG | Recreational Vehicles | 27.56 | 1.43B | 0.00% | 6.15 | 63.13% |
Janus International Group Inc. | JBI | Building Products & Equipment | 9.79 | 1.42B | 2.73% | 11.54 | 116.21% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.92 | 1.24B | 1.91% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.47 | 1.15B | 0.09% | n/a | 19.46% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 23.44 | 1.06B | -0.38% | n/a | 3644.76% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.7 | 793.63M | -0.68% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 1,366.81 | 0.76 | Expensive |
Ent. to Revenue | 5.43 | 3,674.48 | Cheaper |
PE Ratio | - | 38.01 | - |
Price to Book | 1.81 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 54.00 | 74.67 | Lower Risk |
Debt to Equity | 0.30 | -1.82 | Expensive |
Debt to Assets | 0.20 | 0.26 | Cheaper |
Market Cap | 1.78B | 3.73B | Emerging |